Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

ChemoMetec

508.5

 

DKK

 

-3.69 %

Less than 1K followers

CHEMM

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Investor consensus
Compare
-3.69%
+7.41%
-12.48%
+4.59%
+7.37%
+40.01%
-33.7%
+53.86%
+2,211.36%

ChemoMetec specializes in the design, development, and production of patented instruments for cell counting and cell analysis. The company cooperates and statutes agreements with actors such as research institutes, universities, food companies, hospitals, and specialist clinics. Customers are found in a global market. The company was founded in 1997 and is headquartered in Alleröd, Denmark.

Read more
Market cap
8.85B DKK
Turnover
11.3M DKK
Revenue
407.35M
EBIT %
41.48 %
P/E
64.94
Dividend yield-%
0.79 %
Financial calendar
11/9
2025

Annual report '25

9/10
2025

General meeting '25

All
Press releases
ShowingAll content types
Regulatory press release5/7/2025, 3:32 PM

Continued growth in revenue and operating profit

ChemoMetec
Regulatory press release2/10/2025, 3:43 PM

Notification of managers' transactions

ChemoMetec
Regulatory press release2/5/2025, 5:55 PM

Interim report 2024/25 - Solid H1 performance driven by growth in both revenue and earnings

ChemoMetec

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release1/10/2025, 8:47 AM

Upgrade of revenue and operating profit guidance

ChemoMetec
Regulatory press release12/9/2024, 12:35 PM

Major shareholder announcement – AIM International Mutual Funds

ChemoMetec
Regulatory press release12/9/2024, 12:34 PM

Major shareholder announcement – Invesco Ltd.

ChemoMetec
Regulatory press release12/3/2024, 2:56 PM

Upgrade of revenue and operating profit guidance

ChemoMetec
Regulatory press release11/8/2024, 12:28 PM

Notification of managers’ transactions

ChemoMetec
Regulatory press release11/8/2024, 12:26 PM

Notification of managers’ transactions

ChemoMetec
Regulatory press release11/7/2024, 4:12 PM

Growth in revenue and operating profit

ChemoMetec
Regulatory press release10/22/2024, 3:35 PM

Closing of acquisition of Ovizio Imaging Systems SA

ChemoMetec
Regulatory press release10/16/2024, 2:36 PM

Acquisition of Ovizio Imaging Systems SA

ChemoMetec
Regulatory press release10/16/2024, 2:32 PM

Upgrade of revenue and operating profit guidance

ChemoMetec
Regulatory press release10/11/2024, 1:42 PM

ChemoMetec’s potential acquisition of Ovizio Imaging Systems SA

ChemoMetec
Regulatory press release10/10/2024, 8:34 PM

Procedure of the Annual General Meeting

ChemoMetec
Regulatory press release9/20/2024, 3:06 PM

ChemoMetec makes offer to buy Ovizio Imaging Systems SA

ChemoMetec
Regulatory press release9/18/2024, 12:44 PM

Notice of Annual General Meeting 2024

ChemoMetec
Regulatory press release9/13/2024, 7:36 AM

Notification of managers’ transactions

ChemoMetec
Regulatory press release9/11/2024, 8:29 PM

Annual Report 2023/24 - Strengthened commercial focus after challenging year

ChemoMetec
Regulatory press release9/11/2024, 8:27 PM

Guidance for the 2024/25 financial year

ChemoMetec
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team